<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 02 Jun 2026 00:25:32 -0400--><rss version="2.0">
    <channel>
        <title>Immunocore Holdings plc (IMCR) SEC Filings</title>
        <link>https://www.immunocore.com/investors/financials-filings/sec-filings/rss</link>
        <description>Immunocore Holdings plc (IMCR) - SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_b541aae032f58bf8fdbdeabb137fc49f/immunocore/files/theme/images/logo-sm.png</url>
                <title>Immunocore Holdings plc Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001919343-26-000002/0001919343-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:47 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001919343-26-000002/0001919343-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001508596-26-000002/0001508596-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:43 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001508596-26-000002/0001508596-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969518-26-000002/0001969518-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:40 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969518-26-000002/0001969518-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969522-26-000002/0001969522-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:36 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969522-26-000002/0001969522-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969520-26-000002/0001969520-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:32 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969520-26-000002/0001969520-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969932-26-000002/0001969932-26-000002.pdf</link>
                <pubDate>Thu, 28 May 26 19:55:27 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001969932-26-000002/0001969932-26-000002.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[8-K]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-022984/0001140361-26-022984.pdf</link>
                <pubDate>Wed, 27 May 26 16:22:35 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-022984/0001140361-26-022984.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000187/0001974494-26-000187.pdf</link>
                <pubDate>Fri, 22 May 26 15:45:01 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000187/0001974494-26-000187.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000185/0001974494-26-000185.pdf</link>
                <pubDate>Thu, 21 May 26 13:57:22 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000185/0001974494-26-000185.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[2 Related Documents: SCHEDULE 13G, EX-99.1]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0000902664-26-002542/0000902664-26-002542.pdf</link>
                <pubDate>Fri, 15 May 26 17:12:47 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0000902664-26-002542/0000902664-26-002542.pdf</guid>
                                                                            </item>
            </channel>
</rss>